MedPath

Clinical study of cardiopulmonary rehabilitation program of integrated traditional Chinese and western medicine in primary and secondary prevention of coronary heart disease

Phase 1
Recruiting
Conditions
Coronary heart disease/metabolic syndrome
Registration Number
ITMCTR2100004819
Lead Sponsor
Guang'anmen Hospital of China Academy of Traditional Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1. Metabolic syndrome (MS) group:
1) Aged 18 to 65 years;
2) Diagnosed as MS and do not meet the diagnostic criteria for coronary heart disease;
2. Coronary heart disease angina pectoris (SA) group:
1) Aged 18 to 65 years;
2) Diagnosed as SA.

Exclusion Criteria

1. People with mental disorders or movement disorders;
2. Complicated with severe cardiac, cerebral, renal and vascular diseases and instability;
3. Patients with acute coronary syndrome, non-sinus rhythm, atrial fibrillation, atrial flutter, various types of conduction block and ventricular rhythm, etc., and patients with severe cardiopulmonary dysfunction were shown by cardiopulmonary exercise test;
4. Various infections, acute metabolic disorders, diabetic foot and other serious complications of diabetes;
5. Systolic blood pressure >= 200mmHg and/or diastolic blood pressure >= 100mmHg;
6. Pregnant or lactating woman;
7. A past or current history of cancer or other fatal disease that affects short-term survival;
8. Serious bone and joint disease, can not cooperate with the experimenter.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
SAS, SDS score;The Seattle Angina Scale;Seattle Angina Scale score;Quality of Life;6 min walking test;
Secondary Outcome Measures
NameTimeMethod
C-reactive protein, CRP;Uric acid;Blood lipids;HCY(homocysteine);
© Copyright 2025. All Rights Reserved by MedPath